Literature DB >> 1400562

Radiation sensitivities in various anticancer-drug-resistant human lung cancer cell lines and mechanism of radiation cross-resistance in a cisplatin-resistant cell line.

F Oshita1, Y Fujiwara, N Saijo.   

Abstract

To determine whether there exists cross-resistance between anticancer drugs and radiation, six drug-resistant human lung cancer cell lines and their parental cell lines were examined for radiosensitivity using a growth-inhibition assay. Only one cisplatin-resistant cell line, PC-9/CDDP, showed cross-resistance to radiation. The other three cisplatin-resistant cell lines (PC-7/CDDP, PC-4/CDDP, and H69/CDDP), an etoposide-resistant cell line (H69/VP) and a camptothecin-resistant cell line (PC-7/CPT) did not show cross-resistance to radiation. To analyze the mechanism of radiation resistance in PC-9/CDDP cells, the formation and repair of radiation-induced DNA single-strand breaks (ssb) and double-strand breaks (dsb) were examined by alkaline elution and neutral elution respectively. Although the formation of DNA ssb and repair of both DNA ssb and DNA dsb were the same for both cell lines, the formation of DNA dsb in PC-9/CDDP cells was significantly less than those in PC-9 cells. Measurement of intracellular glutathione content in all of the cell lines revealed that only PC-9/CDDP cells had a significant increase of glutathione content compared to the parental cells. Buthionine sulfoximine treatment of PC-9/CDDP cells caused an increase of DNA dsb to the same levels as in PC-9 cells after irradiation and caused a complete radiosensitization. These results indicate that cross-resistance to radiation in drug-resistant cells in a rare phenomenon, and increased glutathione content may play a crucial role in the emergence of cross-resistance to radiation in the drug-resistant cells.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1400562     DOI: 10.1007/bf01209484

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  29 in total

Review 1.  DNA damage and repair following treatment with ionizing radiation.

Authors:  S Powell; T J McMillan
Journal:  Radiother Oncol       Date:  1990-10       Impact factor: 6.280

2.  Characterization of an etoposide-resistant human small-cell lung cancer cell line.

Authors:  K Minato; F Kanzawa; K Nishio; K Nakagawa; Y Fujiwara; N Saijo
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

3.  Faster repair of DNA double-strand breaks in radioresistant human tumor cells.

Authors:  J L Schwartz; J Rotmensch; S Giovanazzi; M B Cohen; R R Weichselbaum
Journal:  Int J Radiat Oncol Biol Phys       Date:  1988-10       Impact factor: 7.038

4.  The level of induced DNA double-strand breakage correlates with cell killing after X-irradiation.

Authors:  I R Radford
Journal:  Int J Radiat Biol Relat Stud Phys Chem Med       Date:  1985-07

5.  Potent and specific inhibition of glutathione synthesis by buthionine sulfoximine (S-n-butyl homocysteine sulfoximine).

Authors:  O W Griffith; A Meister
Journal:  J Biol Chem       Date:  1979-08-25       Impact factor: 5.157

6.  Establishment of a camptothecin analogue (CPT-11)-resistant cell line of human non-small cell lung cancer: characterization and mechanism of resistance.

Authors:  F Kanzawa; Y Sugimoto; K Minato; K Kasahara; M Bungo; K Nakagawa; Y Fujiwara; L F Liu; N Saijo
Journal:  Cancer Res       Date:  1990-09-15       Impact factor: 12.701

7.  X-ray and cis-diamminedichloroplatinum(II) cross-resistance in human tumor cell lines.

Authors:  J L Schwartz; J Rotmensch; M A Beckett; D R Jaffe; M Toohill; S M Giovanazzi; J McIntosh; R R Weichselbaum
Journal:  Cancer Res       Date:  1988-09-15       Impact factor: 12.701

8.  An analysis of induction and adjuvant chemotherapy in the multidisciplinary treatment of squamous-cell carcinoma of the head and neck.

Authors:  T J Ervin; J R Clark; R R Weichselbaum; B G Fallon; D Miller; R L Fabian; M R Posner; C M Norris; S A Tuttle; D A Schoenfeld
Journal:  J Clin Oncol       Date:  1987-01       Impact factor: 44.544

9.  Correlation between response to cisplatinum-combination chemotherapy and subsequent radiotherapy in previously untreated patients with advanced squamous cell cancers of the head and neck.

Authors:  J F Ensley; J R Jacobs; A Weaver; J Kinzie; J Crissman; J A Kish; G Cummings; M Al-Sarraf
Journal:  Cancer       Date:  1984-09-01       Impact factor: 6.860

10.  Determinants of drug response in a cisplatin-resistant human lung cancer cell line.

Authors:  Y Fujiwara; Y Sugimoto; K Kasahara; M Bungo; M Yamakido; K D Tew; N Saijo
Journal:  Jpn J Cancer Res       Date:  1990-05
View more
  5 in total

Review 1.  Human cell lines as models for multidrug resistance in solid tumours.

Authors:  M Clynes; M Heenan; K Hall
Journal:  Cytotechnology       Date:  1993       Impact factor: 2.058

Review 2.  Tumor and host factors that may limit efficacy of chemotherapy in non-small cell and small cell lung cancer.

Authors:  David J Stewart
Journal:  Crit Rev Oncol Hematol       Date:  2010-01-04       Impact factor: 6.312

3.  Helical tomotherapy for asymptomatic chemotherapy-refractory or -unfit multiple (3 or more) metastases.

Authors:  Yuki Yamada; Yuta Shibamoto; Kazushi Kishi; Nozomi Kita; Takuhito Kondo; Taro Murai; Chikao Sugie
Journal:  Rep Pract Oncol Radiother       Date:  2022-03-22

4.  Helical tomotherapy for chemo-refractory multiple liver metastases.

Authors:  Taiki Takaoka; Yuta Shibamoto; Taro Murai; Masanori Kobayashi; Chikao Sugie; Yoshihiko Manabe; Takuhito Kondo; Dai Okazaki; Yuki Yamada; Akira Torii
Journal:  Cancer Med       Date:  2019-10-29       Impact factor: 4.452

Review 5.  Modulating barriers of tumor microenvironment through nanocarrier systems for improved cancer immunotherapy: a review of current status and future perspective.

Authors:  Huanrong Lan; Wei Zhang; Ketao Jin; Yuyao Liu; Zhen Wang
Journal:  Drug Deliv       Date:  2020-12       Impact factor: 6.419

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.